Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials

Authors:

Abstract
No abstract available
Funding Information
  • Deutsche Krebshilfe (110460)
  • National Cancer Institute (R01CA182551)
  • National Cancer Institute (P30CA008748)
  • National Cancer Institute (T32 CA009501)

This publication has 10 references indexed in Scilit: